Oregon OTC-To-Rx Pseudoephedrine Bill Challenges FDA Authority - Lawyers
This article was originally published in The Tan Sheet
Executive Summary
An Oregon meth control bill making pseudoephedrine products available only by prescription encroaches on FDA's authority over the classification of drugs, according to some food & drug law experts
You may also be interested in...
Combat Meth Act Heads To Senate Floor Without Federal Preemption Clause
The Senate Judiciary Committee unanimously passed the Combat Meth Act of 2005 (S 103) July 28 after adopting an amendment that strikes the federal preemption provision from the bill
Oregon Pseudoephedrine Prescription Status Bill Heads To Senate
A bill that would require a prescription for purchase of products containing pseudoephedrine and other methamphetamine precursors passed the Oregon House of Representatives July 20
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC